Shom Goel, Isabel Blancas, Giacomo Allegrini, Jose Luis Alonso-Romero, Alvaro Rodriguez-Lescure, Sara Lopez-Tarruella Cobo, Aleksandra Grela-Wojewoda, Thomas Grinda, Cristian Villanueva, Samanta Sarti, Christian Kurzeder, Ilke Cikman, Muralidhar Beeram, Kuo-Ting Lee, Cynthia Basu, Sindy Kim, Feng Liu, Jin Yao, Michail Ignatiadis. "Neoadjuvant atirmociclib plus letrozole versus letrozole alone in HR+/HER2− breast cancer: Results from FourLight-2, a randomized phase 2 window of opportunity study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.518